Our upper reference limits in adults are 130 IU/l for total ALP, 60 IU/l for liver ALP, 70 IU/l for bone ALP and 20 IU/l for intestinal ALP, independent of blood group. The detection limit of the electrophoretic method is less than 5 IU/l Five families were studied.
A persistent increase in plasma alkaline phosphatase (Orthophosphoric monoester phosphohydrolase (alkaline optimum) EC 3-1-3-1; ALP) in the absence of clinical evidence of disease is most often a consequence of occult bone or liver disorder. This is generally indicated by the appropriate biochemical, radiological, scintigraphic, or biopsy investigations. Despite this, there are some patients who show no other abnormality for whom measurement of plasma ALP isoenzymes, preferably by electrophoresis, is mandatory. This may show an increase in bone or liver fraction, but, sometimes, an unexpected increase in intestinal origin phosphatase may also be found. This persists in fasting samples. A raised intestinal fraction is well recognised in association with hepatic cirrhosis,' chronic renal failure,2 or diabetes mellitus,3 but the possibility of a genetic origin is frequently overlooked.4 It is our practice to recommend family studies whenever a persistent increase in the intestinal fraction is found in the absence of the above disorders. Consequently, when first degree relatives were available for study, we were able to show the presence of an inherited hyperphosphatasaemia in several such patients.
Methods
Fasting samples were requested from all family members. Total ALP activity was measured in accordance with the International Federation of Clinical Chemistry (IFCC) recommendations, but at 37°C.5 ALP isoenzymes were separated and quantified by wheat germ lectin affinity electrophoresis with densitometric scanning.6 Liver and bone ALP migrated in the a2-globulin position. ALP migrating in the fl-globulin position was confirmed as intestinal by retardation after preincubation with specific monoclonal antibody. Intestinal-variant ALP7 was shown as activity remaining in the a2-globulin region after prolonged sample preincubation with neuraminidase. 8 Our upper reference limits in adults are 130 IU/l for total ALP, 60 IU/l for liver ALP, 70 IU/l for bone ALP and 20 IU/l for intestinal ALP, independent of blood group. The detection limit of the electrophoretic method is less than 5 IU/l Five families were studied.
FAMILY 1
The propositus JP) was a 30 year old woman with a persistent, unexplained, increase in plasma ALP of about two and a half times the upper reference limit. Isoenzyme electrophoresis showed a mild increase in the liver ALP fraction together with a substantial increase in the intestinal isoenzyme, confirmed by retardation of mobility following incubation with anti-intestinal ALP monoclonal antibody. Because of the increase in intestinal ALP, family studies were advised. The father and mother were both clinically normal, but both showed raised total ALP activity. In the father there was a mild increase in total ALP and in the liver fraction, borderline bone isoenzyme activity, and an increased intestinal fraction. ALP of slow a,-mobility ("slow a,-ALP"), just anodal to liver ALP, was also detected. The mother also showed raised total ALP activity, with an increase in the liver fraction. apart from a mild increase in plamsa bilirubin which varied between 29 and 39 pmol/l, and which was diagnosed as being due to Gilbert's disease. Isoenzyme examination showed normal liver and bone fractions but the intestinal fraction was substantially increased and accounted for most of the ALP activity. ALP in the slow a,-position was also present. Family studies were suggested, and specimens were obtained from both parents and an older brother. Both parents showed normal total ALP activity and normal bilirubin values. Liver, bone, and intestinal ALP were detectable in the plasma of the father but none of these fractions was increased. In the mother, however, the intestinal fraction was substantially increased and staining in the slow a,-position was seen. In the brother liver and bone ALP were both present at normal activity, together with a borderline intestinal ALP fraction. Results are shown in table 1. FAMILY 3 A 53 year old woman with persistent unexplained hyperphosphatasaemia-total activity about two and a half times the upper reference limit-had a slight increase in the liver fraction by isoenzyme electrophoresis together with a pronounced increase in intestinal ALP, the latter accounting for more than 50% of total ALP activity. ALP in the slow a,-region was also present. Pre-incubation with anti-intestinal monoclonal antibody retarded the mobility of the intestinal fraction with accompanying disappearance of the slow a,-band, possibly because of its retardation and incorporation within liver ALP. A sample was obtained from her daughter, aged 28 . This also showed increased intestinal ALP, accounting for 40% of her total ALP.
Samples from two other daughters, aged 26 and 24, showed normal total ALP and isoenzyme values. A son aged 27, however, had a borderline total value, with a barely increased intestinal ALP value (table 1) . Intestinal-variant ALP was shown in the a,-globulin region after prolonged treatment with neuraminidase of samples from the patient, the eldest daughter, and the son. FAMILY 4 A 55 year old woman without any clinical symptoms had shown a persistent increase in ALP over a two year period. Isoenzyme examination of the patient's plasma at St James's Hospital, Leeds (Dr RB Payne) had shown high ALP activity in the intestinal position and the sample was referred for confirmation. ALP activity was about twice the upper reference limit of normal and the sample showed increased activity of liver, bone, and intestinal phosphatase, together with some staining in the slow a,-region. Preincubation with anti-intestinal ALP monoclonal antibody produced changes similar to that seen in the propositus case of family 3. A possible genetic abnormality was suggested and samples from two sisters, two sons, and two daughters were forwarded for examination. An elder sister aged 69 had ALP activity about four times the upper reference limit with an increased bone fraction. A second sister aged 66 had a total ALP value about two and a half times the upper reference limit, together with increased liver, bone, and intestinal ALP. Intestinal-variant ALP activity was detected in this plasma following prolonged pre-incubation with neuraminidase. A 23 year old son had total ALP activity about one and a half times the upper reference limit, with increased liver and bone fractions and borderline intestinal ALP activity. A 22 year old daughter had total ALP activity at the upper reference limit of normal with a raised bone fraction. Two other children, a daughter aged 25 and a son aged 27, had normal total activity and isoenzyme distribution (table 1) . ALP isoenzyme electrophoretic pattems on various family members are shown in the figure. FAMILY 5 A 44 year old man had had unexplained raised ALP activity for three years. He was overweight and hypertensive; his total ALP activity was noted (Dr J Went, Derriford Hospital, Plymouth) to be about three and a half times the upper reference limit, with the presence of intestinal isoenzyme. We found an increase in the liver, bone, and intestinal fractions, together with two faint-staining bands just in advance of the liver fraction in the slow a, position. These and the intestinal fraction showed the same response to preincubation with anti-intestinal ALP monoclonal antibody as that noticed in the two previous families. Specimens were made available from the patient's mother, sister, and half-sister (same mother, different father). The increased total ALP with a borderline increase in bone fraction. Intestinal ALP was present but not raised. The 41 year old sister, however, had total ALP three times the upper reference limit, with a borderline increase in liver but a definite increase in bone and intestinal ALP, the latter accounting for nearly 50% of total activity. Samples from the sister also showed two faint-staining bands in advance of the liver fraction. Pre-treatment with neuraminidase of this plasma showed intestinal-variant ALP activity, together with persistence of the slow a,-band. Plasma from the half-sister showed normal total ALP and isoenzyme fractions (table 1) .
Discussion
Inherited increased ALP in the absence of disease was first reported by Wilson in 1979 in a 15 year old boy.4 Total ALP was more than 12 times the upper reference limit and the bone and liver fractions were increased. ALP values two to four times the upper reference limit were also present in the subject's father, paternal grandfather, and two aunts, and on this basis a dominant inheritance pattern was suggested. In 1979, an unusual inherited ALP isoenzyme variant was also reported from the Husavik region of Iceland.9 This variant was seen as an additional band of greater electrophoretic mobility than liver ALP, migrating between this fraction and albumin. It was heat stable, uninhibited by phenylalanine, and not retarded by neuraminidase. It was found in 10 out of 343 subjects studied, nine of whom were female and nine of whom were related by common ancestry. All subjects were healthy so an autosomal dominant pattern of inheritance was postulated. In these subjects, however, total ALP was not increased. Since that time several reports of benign familial increase in plasma ALP activity have appeared (table  2) ,125 most with an autosomal dominant pattern of inheritance. Such an inheritance pattern has also been observed in a family with concomitant Gilbert's disease. 24 In this family an autosomal codominant inheritance pattern was considered a more likely explanation for 
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Inherited increase of either a single isoenzyme fraction-for example, either bone or intestinal ALP, rarely placental-like ALP-or of multiple fractions-for example, liver and bone ALP together or each with intestinal ALP-has been observed (our family 4).2°T he liver, bone, and kidney forms of ALP are thought to be coded at a single locus (the tissue-non-specific ALP gene) on chromosome 1, whereas the intestinal and placental are coded at separate loci on chromosome 2.2&28 Isoenzyme changes may thus represent a change in the products of a single gene (where only a single fraction or liver and bone in combination are increased) or of separate genes (where liver or bone isoenzyme increase is accompanied by raised intestinal ALP). To account for such changes various mechanisms have been proposed,20 including mutation affecting gene structure and expression (which would affect individual isoenzymes) or of regulator genes or of genes controlling post-translational modification, or enzyme attachment to or release from cell membranes (which could increase the plasma activity of isoenzymes coded at separate loci).
In non-genetic disorders giving rise to increased intestinal ALP (fl-globulin mobility) in plasma, the accompanying presence of socalled "intestinal-variant" (hydrophobic) ALP can frequently be shown, this fraction resulting from release of intestinal ALP into the circulation with attached membrane binding domain.78 Intestinal-variant ALP in plasma has been reported in familial hyperphosphatasaemia23-25 and accompanied an increase in intestinal ALP in various members of three of our five families. We have also noticed a staining band in advance of liver ALP (of slow a,-mobility) and retarded by anti-intestinal antibody in members of each of the families we studied. The relevance of this intestinal-like ALP is uncertain.
Where a persistent increase in ALP is accompanied only by an increase in the liver or bone fractions, consideration of a possible genetic abnormality is likely to be much delayed while an extensive search for liver or bone disease is carried out. Where a raised intestinal fraction is observed, however, a genetic disorder may be more readily suspected because the other disorders associated with such increases are few and generally obvious. An inherited cause should be particularly suspected when the intestinal fraction is concomitantly accompanied by an increase in the liver and bone fractions. A persistent increase in intestinal ALP without obvious clinical explanation has, however, also been reported in individuals in whom family studies have failed to show any evidence of heritability. 29 
31
After coming across five examples within 18 months, we suggest that inherited increase in ALP activity deserves wider recognition as a cause of hyperphosphatasaemia, especially in the absence of overt disease, and should be particularly suspected when the intestinal fraction is increased.
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